Trials / Terminated
TerminatedNCT03091855
PLUG Dementia Trial and MRI PLUG Dementia Sub-Study
Overall and MRI-based Impact of Percutaneous Left Atrial Appendage Closure on the Cognitive Decline and Dementia in Patients With Atrial Fibrillation (PLUG Dementia Trial and MRI PLUG Dementia Sub-Study)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 22 (actual)
- Sponsor
- Intermountain Health Care, Inc. · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
PLUG Dementia Trial: Patients will be screened at Intermountain Medical Center and at Intermountain affiliated anticoagulation clinics in the Salt Lake City region. Patients with atrial fibrillation that undergo a standard of care, clinically approved, left atrial appendage closure will be considered for study. All patients will be followed for 24 months, and will be assessed at the 3-, 6-, 12-, 18- and 24-months post-left atrial appendage closure as well as other visits deemed necessary for clinical care. All subjects will undergo protocol-specified laboratory tests and will complete 6 standard, validated questionnaires at each follow-up visit, except at the 3-month visit when only one questionnaire will be administered. A subset of patients (n=20), will receive a cranial MRI at baseline and 24-month visit. MRI PLUG Dementia Sub-Study: In addition to the above, 20 of the 60 subjects who are selected for participation in this sub-study will receive a cranial MRI at baseline and at the 2-year (24 months) follow-up visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire | Alzheimer's Disease Assessment Scale (ADAS-cog11) and Disability Assessment for Dementia (DAD) Questionnaires |
| DIAGNOSTIC_TEST | Magnetic Resonance Imaging | MRI at baseline and at 24 months post-enrollment for 20 sub-study participants |
Timeline
- Start date
- 2017-04-03
- Primary completion
- 2021-01-08
- Completion
- 2021-01-08
- First posted
- 2017-03-27
- Last updated
- 2021-04-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03091855. Inclusion in this directory is not an endorsement.